The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement of new tariffs on imported goods – 25% on Canada
Sanofi bought back a €3bn stake earlier this week held by L’Oréal. Image credit: Shutterstock / LCV. Just days after taking back some of the
Vancouver, Canada, Feb. 04, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of
VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical
TORONTO, Feb. 06, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the
TORONTO, Feb. 03, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused
In this Issue The Psychedelic Blame Game: NYT Report Fuels Controversy Over MDMA Rejection Mixed Messages on Psymposia’s Role Lykos and MAPS Seize the Opportunity
The CoppaFeel! x NHS NELCA ‘Check In’ campaign transforms breast cancer awareness for young people, addressing health inequities and promoting self-checking.
The executive team of Alumis will lead the combined entity. Credit: Asian Isolated/Shutterstock. Alumis and Acelyrin have announced a definitive merger agreement, which will result
Morning. Today, we have a look at the White House’s reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding